@article{06a1acb384e84b9686a69a0a87b88107,
title = "A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany",
abstract = " In Germany, the recently approved 20-valent pneumococcal conjugate vaccine had a substantially higher coverage against pneumonia in adults than the 13-valent vaccine, while the coverage gap compared to the 23-valent polysaccharide vaccine was small https://bit.ly/3q4skov ",
author = "Christina Bahrs and Miriam Kesselmeier and Martin Kolditz and Santiago Ewig and Gernot Rohde and Grit Barten-Neiner and Jan Rupp and Martin Witzenrath and Tobias Welte and Pletz, {Mathias W.}",
note = "Funding Information: (CM-COVID). This study was supported by an unrestricted grant from Pfizer. Funding Information: Teva, and research funding from Actelion, Bayer Health Care, Biotest, Funding Information: partly supported by a grant of the Federal Ministry of Education and Research",
year = "2022",
month = feb,
day = "1",
doi = "10.1183/13993003.02432-2021",
language = "English",
volume = "59",
journal = "European Respiratory Journal",
issn = "0903-1936",
number = "2",
}
